ORPHA:54595
Craniopharyngioma
Publications
13,900
98.1th percentile
Trials
44
Interventional, condition-specific
Researchers
1,219
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare neoplastic/endocrine disease characterized by benign slow growing tumors of low-grade histological malignancy (WHO grade 1) that are located within the sellar and parasellar regions of the skull base.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018907
- MeSH:D003397
- UMLS:C0010276
- NCIT:C2964
Additional Mondo synonyms (12)
Rathke pouch neoplasm · Rathke pouch tumor · Rathke pouch tumour · Rathke's pouch neoplasm · Rathke's pouch tumor · Rathke's pouch tumour · craniopharyngioma (WHO grade I) · craniopharyngioma (morphologic abnormality) · craniopharyngioma, benign · neoplasm of Rathke's pouch · tumor of Rathke's pouch · tumour of Rathke's pouch
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
13,900 matched papers (6,782 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
44 matched on ClinicalTrials.gov (9 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
13,900
13,900 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
13,900 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
6,782 in the last 10 years · medium confidence · 98.1th percentile (publications denominator)
Phrase hits: 13,900 · MeSH hits: 283
Who's working on it?
1,219
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Couldwell WT7 papers · 2026
Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
Papers in Europe PMC - 02Hong T7 papers · 2026
Jiangxi Key Laboratory of Neurological Diseases, Department of Neurosurgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yong Wai Zheng Street, Nanchang, 330006, China. ndyfy00567@ncu.edu.cn.
Papers in Europe PMC - 03Rennert RC7 papers · 2026
Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
Papers in Europe PMC - 04Barkhoudarian G6 papers · 2026
Department of Neurosurgery, Pacific Neuroscience Institute, Providence St. Johns Medical Center, Santa Monica, California, USA.
Papers in Europe PMC - 05Chicoine MR6 papers · 2026
Department of Neurosurgery, University of Missouri, Columbia, Missouri, USA.
Papers in Europe PMC - 06Evans JJ6 papers · 2026
Department of Neurosurgery, Jefferson University, Philadelphia, Pennsylvania, USA.
Papers in Europe PMC - 07Fernandez-Miranda JC6 papers · 2026
Department of Neurosurgery, Stanford University, Palo Alto, California, USA.
Papers in Europe PMC - 08Karsy M6 papers · 2026
Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.
Papers in Europe PMC - 09Kim AH6 papers · 2026
Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Papers in Europe PMC - 10Kim W6 papers · 2026
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
44
interventional trials for this specific condition
44 interventional trials matched this specific condition name; 9 currently recruiting in our sample.
Data as of 27 July 2026
44 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 96.7th percentile).
medium confidence · 96.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
44 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT05465174·RECRUITING·Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Conditions: Craniopharyngioma, Child · Craniopharyngioma · Recurrent Craniopharyngioma·Matched via name + MeSH
- NCT07177482·RECRUITING·ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Conditions: Craniopharyngioma·Matched via name + MeSH
- NCT05286788·RECRUITING·MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Conditions: Adamantinous Craniopharyngioma · Recurrent Adamantinomatous Craniopharyngioma·Matched via name + MeSH
- NCT05919264·RECRUITING·FOG-001 in Locally Advanced or Metastatic Solid Tumors
Conditions: Cancer · Colorectal Cancer · Solid Tumor · Locally Advanced Solid Tumor·Matched via name + MeSH
- NCT05233397·RECRUITING·ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Conditions: Adamantinomatous Craniopharyngioma · Recurrent Adamantinomatous Craniopharyngioma·Matched via name + MeSH
- NCT07316101·RECRUITING·Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Conditions: Pituitary Adenoma · Craniopharyngioma·Matched via name + MeSH
- NCT06970145·RECRUITING·Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Conditions: Craniopharyngiomas·Matched via name + MeSH
- NCT06299891·RECRUITING·Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Conditions: Hypothalamic Obesity · Hypothalamic Tumor · Craniopharyngioma·Matched via name + MeSH
- NCT05525273·RECRUITING·Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Conditions: Craniopharyngioma·Matched via name + MeSH
Observational and natural-history studies
16 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07301554·NOT YET RECRUITING·Food Preferences and Craniopharyngiomas
Conditions: Craniopharyngioma·Matched via name + MeSH
- NCT07703605·NOT YET RECRUITING·AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
Conditions: Pediatric Brain Tumors · Glioma · Medulloblastoma · Ependymoma·Matched via name + MeSH
- NCT06874426·RECRUITING·The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Conditions: Meningioma · Pituitary Disease · Pituitary Adenoma · Craniopharyngioma·Matched via name + MeSH
- NCT03610906·ENROLLING BY INVITATION·Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Conditions: Craniopharyngioma, Child·Matched via name + MeSH
- NCT04648462·RECRUITING·Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Conditions: Astrocytoma · Ependymoma · Ganglioglioma · Oligodendroglioma·Matched via name + MeSH
- NCT06801756·RECRUITING·Craniopharyngioma and Pregnancies
Conditions: Craniopharyngioma·Matched via name + MeSH
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Craniopharyngioma" OR "Rathke pouch neoplasm" OR "Rathke pouch tumor" OR "Rathke pouch tumour" OR "Rathke's pouch neoplasm" OR "Rathke's pouch tumor" OR "Rathke's pouch tumour" OR "craniopharyngioma (WHO grade I)" OR "craniopharyngioma (morphologic abnormality)" OR "craniopharyngioma, benign" OR "neoplasm of Rathke's pouch" OR "neoplasm of the Rathke's pouch" OR "tumor of Rathke's pouch" OR "tumor of the Rathke's pouch" OR "tumour of Rathke's pouch" OR "tumour of the Rathke's pouch"
MeSH descriptor terms unioned into the query: Craniopharyngioma
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Craniopharyngioma" OR "Rathke pouch neoplasm" OR "Rathke pouch tumor" OR "Rathke pouch tumour" OR "Rathke's pouch neoplasm" OR "Rathke's pouch tumor" OR "Rathke's pouch tumour" OR "craniopharyngioma (WHO grade I)" OR "craniopharyngioma (morphologic abnormality)" OR "craniopharyngioma, benign" OR "neoplasm of Rathke's pouch" OR "neoplasm of the Rathke's pouch" OR "tumor of Rathke's pouch" OR "tumor of the Rathke's pouch" OR "tumour of Rathke's pouch" OR "tumour of the Rathke's pouch"
Interventional trials matched via: both (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 44 interventional · 16 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T00:57:21.934Z
